Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin 18 pseudogene 4 (SNX18P4) is a non-protein-coding pseudogene annotated by the HGNC and does not code for any known functional protein or therapeutic receptor/enzyme[2]. Pseudogenes are DNA sequences similar to normal genes but lack function due to mutations, deletions, or incomplete transcription/translation. SNX18P4 has no described biological activity, function in cellular processes, or implication in disease, nor does it have known drugs or safety concerns. Its parent gene, sorting nexin 18 (SNX18), is involved in membrane trafficking and autophagy, but SNX18P4 itself does not code for this protein and is not considered a drug target[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin 18 pseudogene 4 (SNX18P4).